Provenienza dei contatti di primo grado di Patti Ketchner
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA.
28
| Extinct | Miscellaneous Commercial Services | 28 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Patti Ketchner tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Human Resources Officer Director/Board Member | |
| FIBROCELL SCIENCE, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| GLOBEIMMUNE, INC. | Pharmaceuticals: Other | Director/Board Member | |
Galleon Pharmaceuticals, Inc.
 Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galleon Pharmaceuticals, Inc. develops and manufactures medicines for breathing-control conditions. Its product pipeline addresses the needs of both acute and chronic care patients. The firm's GAL-021 product is a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients, and in particular those high risk patients with sleep apnea who are undergoing surgery. The company was founded by James C. Mannion in 2003 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | Director/Board Member | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Founder | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Scioderm, Inc.
 Scioderm, Inc. BiotechnologyHealth Technology Scioderm, Inc. engages in the development of innovative therapies for areas of high unmet need, including orphan products. The company was founded by Robert Ryan and Robert John Coull in 2012 and is headquartered in Durham, NC. | Biotechnology | Chairman | |
| WAVE LIFE SCIENCES LTD. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Masters Business Admin | |
National Genetics Institute, Inc.
 National Genetics Institute, Inc. Chemicals: SpecialtyProcess Industries Part of Laboratory Corp. of America Holdings, National Genetics Institute, Inc. provides hepatitis C testing and other laboratory services. The company is based in Los Angeles, CA. The company was founded by Andrew J. Conrad, Michael A. Aicher. National Genetics Institute was acquired by Laboratory Corp. of America Holdings on August 01, 2000. | Chemicals: Specialty | Corporate Officer/Principal | |
| California State University-Northridge | College/University | Masters Business Admin | |
| Cornell College (Iowa) | College/University | Undergraduate Degree | |
| Indiana University | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Masters Business Admin Doctorate Degree | |
| The University of Colorado | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of La Verne | College/University | Doctorate Degree | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Atugen AG
 Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Pharmaceuticals: Major | Chairman Director/Board Member | |
Morgenthaler Management Corp.
 Morgenthaler Management Corp. Investment ManagersFinance Morgenthaler Management Corp (Morgenthaler Management) is a venture capital and private equity firm founded in 1968 by David Morgenthaler. The firm is headquartered in Portola Valley, California. | Investment Managers | Private Equity Investor | |
| The Colorado Bar Association | Corporate Officer/Principal Corporate Officer/Principal | ||
| AUSPEX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| CALITHERA BIOSCIENCES, INC. | Biotechnology | Chairman | |
| PHIO PHARMACEUTICALS CORP. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Berlex Laboratories, Inc. | Director of Finance/CFO Chairman | ||
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Miscellaneous Commercial Services | Director/Board Member | |
| Sturm College of Law | College/University | Graduate Degree Graduate Degree | |
| TME PHARMA N.V. | Biotechnology | Director/Board Member | |
Alveo Technologies, Inc.
 Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Medical Specialties | Founder | |
Meissa Vaccines, Inc.
 Meissa Vaccines, Inc. BiotechnologyHealth Technology Meissa Vaccines, Inc. operates as a pharmaceutical development company. It focuses on the in-licensing and advancement of vaccines for respiratory syncytial virus. The company was founded by Marty Moore and Roderick Tang in 2014 and is headquartered in South San Francisco, CA. | Biotechnology | Chairman | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer President | |
BioIntelliSense, Inc.
 BioIntelliSense, Inc. Packaged SoftwareTechnology Services BioIntelliSense, Inc. engages in developing a medical grade data services platform for continuous health monitoring, predictive analytics and algorithmic clinical insights. The company was founded by James Ritchie Mault in 2018 and is headquartered in Redwood City, CA. | Packaged Software | Director/Board Member | |
| Harborpath, Inc. | Director/Board Member | ||
| ADHERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor |
Statistiche
Distribuzione geografica
| Stati Uniti | 47 |
| Germania | 3 |
| Singapore | 2 |
| Irlanda | 2 |
Settori
| Health Technology | 34 |
| Consumer Services | 9 |
| Commercial Services | 3 |
| Finance | 3 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 224 |
| Corporate Officer/Principal | 65 |
| Independent Dir/Board Member | 45 |
| Director of Finance/CFO | 40 |
| Chairman | 39 |
Contatti più connessi
| Insiders | |
|---|---|
| Jeremy Curnock-Cook | 60 |
| Bryan Roberts | 44 |
| Dennis Langer | 40 |
| Bharatt Chowrira | 24 |
| Chris Christoffersen | 24 |
| R. Greer | 23 |
| Gregory Weaver | 22 |
| Martin Schmieg | 20 |
| Nassim Usman | 15 |
| Douglas Fambrough | 14 |
| James Niedel | 14 |
| Lawrence Blatt | 13 |
| Mark Litton | 11 |
| Barry A. Polisky | 11 |
| John J. Schembri | 10 |
- Borsa valori
- Insiders
- Patti Ketchner
- Connessioni Società
